KISEKI cultivates medical cannabis using sustainable plant factory technology, not only for the Thai market but also for distribution in Europe, Australia, and eventually the U.S., following federal legalization.

Data-Driven Agriculture:

KISEKI employs a data-driven approach to agriculture, fully controlling the environment to ensure stable quality by minimizing fluctuations in temperature, humidity, CO2 levels, ventilation, lighting, and airflow. This approach accelerates data collection, ensuring optimal growing conditions at all times and enabling the production of the highest-quality medical cannabis.

Instead of traditional irrigation methods, KISEKI utilizes drip irrigation, reducing water usage by approximately 1/50 compared to conventional farming while delivering nutrients precisely as needed. Additionally, by using energy-efficient LED lights instead of traditional HPS (High-Pressure Sodium) lamps, significant energy savings are achieved. These practices contribute to a sustainable production system and align with the Sustainable Development Goals (SDGs).

KISEKI’s advanced cultivation techniques allow for up to six harvests per year. The use of drip irrigation minimizes the risk of pests and ensures consistent quality, providing a stable supply of high-grade medical cannabis. These innovations enhance harvest reliability and maximize production efficiency.

Asia’s Leading Medical Cannabis Plant Factory

Located in Bangkok, KISEKI’s medical cannabis farm is one of Asia’s largest facilities with controlled environments, covering approximately 2,000 square meters. The facility has an annual production capacity of around 1,000 kg. Additionally, the farm uses an automated irrigation system capable of applying 64 different fertilization patterns tailored to each growth stage, combined with proprietary pest control methods to ensure the production of the highest quality medical cannabis.

KISEKI has also obtained licenses in Thailand for the cultivation, sale, export, and import of medical cannabis, and has achieved the CUMCS-GAP (Control Union Medical Cannabis Good Agriculture Practice: GACP) certification, one of the strictest standards globally. As of August 2025, only a handful of the approximately 5,000 cannabis companies in Thailand have obtained this certification. KISEKI is proud to be the first Japanese company to legally export medical cannabis from Asia to Europe under its own brand.

Focus on Quality, Safety, and Compliance

At KISEKI, quality, safety, and compliance are top priorities. The controlled environment in our plant factory effectively mitigates the risks of pests and mold. We rigorously test for cannabinoid content, pesticide residues, and mold to ensure the safety of our products. Furthermore, no pesticides are used after flowering, and no synthetic plant growth regulators (PGRs) are employed, resulting in more natural and safer products. KISEKI’s hydroponic system drip irrigation also eliminates the risk of heavy metal contamination, ensuring the highest standards of product safety.

Flower Portfolio